Structures by: Bustos C.
Total: 36
C11H10N4O3
C11H10N4O3
New J. Chem. (2015) 39, 6 4295
a=11.765(4)Å b=11.314(6)Å c=17.774(12)Å
α=90° β=95.75(4)° γ=90°
C11H10Br1N3O1
C11H10Br1N3O1
New J. Chem. (2015) 39, 6 4295
a=13.5334(6)Å b=12.3004(8)Å c=28.098(2)Å
α=90° β=102.177(6)° γ=90°
C10H8Cl1N3O2
C10H8Cl1N3O2
New J. Chem. (2016) 40, 3 2156
a=7.642Å b=7.933Å c=9.511Å
α=98.77° β=104.53° γ=98.06°
C10H8Cl1N3O2
C10H8Cl1N3O2
New J. Chem. (2016) 40, 3 2156
a=12.577(3)Å b=8.509(8)Å c=20.565(6)Å
α=90° β=102.90(2)° γ=90°
Mo16O52Tb,5(C16H36N),6(C2H3N)
Mo16O52Tb,5(C16H36N),6(C2H3N)
Dalton transactions (Cambridge, England : 2003) (2016) 45, 42 16653-16660
a=25.0421(7)Å b=17.1885(5)Å c=31.9702(9)Å
α=90.00° β=91.419(2)° γ=90.00°
Mo16O52Ho,5(C16H36N),8(C2H3N)
Mo16O52Ho,5(C16H36N),8(C2H3N)
Dalton transactions (Cambridge, England : 2003) (2016) 45, 42 16653-16660
a=17.88390(15)Å b=32.8402(2)Å c=47.8961(4)Å
α=90.00° β=90.00° γ=90.00°
Mo16O52Er,5(C16H36N),8(C2H3N)
Mo16O52Er,5(C16H36N),8(C2H3N)
Dalton transactions (Cambridge, England : 2003) (2016) 45, 42 16653-16660
a=17.8110(3)Å b=33.1580(5)Å c=48.1554(8)Å
α=90.00° β=90.00° γ=90.00°
Mo16O52Yb,5(C16H36N),8(C2H3N)
Mo16O52Yb,5(C16H36N),8(C2H3N)
Dalton transactions (Cambridge, England : 2003) (2016) 45, 42 16653-16660
a=17.8722(3)Å b=32.7932(5)Å c=47.8651(7)Å
α=90.00° β=90.00° γ=90.00°
C20H32Mo10N6O38Tb,3(C16H36N),1.5(CHCl3)
C20H32Mo10N6O38Tb,3(C16H36N),1.5(CHCl3)
Dalton transactions (Cambridge, England : 2003) (2016) 45, 42 16653-16660
a=17.4477(3)Å b=17.8961(4)Å c=20.6994(4)Å
α=100.0160(10)° β=98.8610(10)° γ=116.8410(10)°
C20H32DyMo10N6O38,3(C16H36N),1.5(CHCl3)
C20H32DyMo10N6O38,3(C16H36N),1.5(CHCl3)
Dalton transactions (Cambridge, England : 2003) (2016) 45, 42 16653-16660
a=17.4104(6)Å b=17.9043(7)Å c=20.6847(8)Å
α=100.034(2)° β=98.873(2)° γ=116.854(2)°
Mo16O52Tm,5(C16H36N),8(C2H3N)
Mo16O52Tm,5(C16H36N),8(C2H3N)
Dalton transactions (Cambridge, England : 2003) (2016) 45, 42 16653-16660
a=17.8375(2)Å b=32.8499(4)Å c=47.7986(8)Å
α=90.00° β=90.00° γ=90.00°
C20H32ErMo10N6O38,3(C16H36N),C4H8O
C20H32ErMo10N6O38,3(C16H36N),C4H8O
Dalton transactions (Cambridge, England : 2003) (2016) 45, 42 16653-16660
a=25.7069(5)Å b=21.3819(4)Å c=19.9702(3)Å
α=90° β=107.2300(10)° γ=90°
C20H32HoMo10N6O38,3(C16H36N),CHCl3
C20H32HoMo10N6O38,3(C16H36N),CHCl3
Dalton transactions (Cambridge, England : 2003) (2016) 45, 42 16653-16660
a=25.8182(6)Å b=21.3845(5)Å c=19.7951(4)Å
α=90° β=106.8660(10)° γ=90°
C20H32Mo10N6O38Yb,3(C16H36N),CHCl3
C20H32Mo10N6O38Yb,3(C16H36N),CHCl3
Dalton transactions (Cambridge, England : 2003) (2016) 45, 42 16653-16660
a=25.7981(4)Å b=21.3853(3)Å c=19.7968(3)Å
α=90° β=107.0700(10)° γ=90°
(2'<i>E</i>,2'<i>E</i>)-2,2'-(Propane-1,2-diylidene)bis[1-(2-nitrophenyl)hydrazine]
C15H14N6O4
Acta Crystallographica Section C (2015) 71, 12
a=7.9382(16)Å b=7.3484(15)Å c=25.847(5)Å
α=90° β=90.05(3)° γ=90°
(2<i>Z</i>,3<i>Z</i>)-Ethyl 3-[2-(2-nitrophenyl)hydrazinylidene]-2-[2-(4-nitrophenyl)hydrazinylidene]butanoate tetrahydrofuran hemisolvate
C18H18N6O6,0.5(C4H8O)
Acta Crystallographica Section C (2015) 71, 12
a=27.312(6)Å b=7.5929(16)Å c=20.625(4)Å
α=90° β=106.241(7)° γ=90°
4-{3,5-Dimethyl-4-[(E)-(4-methylphenyl)diazenyl]-1H-pyrazol-1-yl}benzonitrile
C19H17N5
Acta Crystallographica Section E (2006) 62, 6 o2499-o2501
a=9.3464(18)Å b=9.4021(18)Å c=10.422(2)Å
α=108.580(3)° β=98.301(4)° γ=103.722(4)°
2-[(E)-(3,5-dimethylisoxazol-4-yl)diazenyl]benzoic acid
C12H11N3O3
Acta Crystallographica Section E (2006) 62, 2 o595-o597
a=7.3550(10)Å b=11.6182(15)Å c=13.6335(17)Å
α=90° β=90° γ=90°
3,5-Dimethyl-1-(4-nitrophenyl)-4-[(E)-(2,3,4,5,6-pentafluorophenyl)diazenyl]- 1H-pyrazole
C17H10F5N5O2
Acta Crystallographica Section E (2007) 63, 3 o1138-o1139
a=5.9868(16)Å b=15.073(4)Å c=19.010(5)Å
α=90° β=92.557(4)° γ=90°
Bis[2-(2,4-dioxopentan-3-ylidene-κO)-1-(4-methoxyphenyl)hydrazinato- κN^1^]copper(II)
C24H26CuN4O6
Acta Crystallographica Section E (2007) 63, 3 m670-m672
a=13.6125(17)Å b=7.5417(9)Å c=23.135(3)Å
α=90° β=90° γ=90°
(2,2-bipyridine-κ^2^N,N')dibromo-<i>cis</i>-bis[1,1- diphenylhydrazido(2-)]molybdenum(VI)
C34H28Br2MoN6
Acta Crystallographica Section E (2006) 62, 11 m3104-m3106
a=9.7449(11)Å b=10.6706(12)Å c=17.883(2)Å
α=96.731(2)° β=98.989(2)° γ=117.028(2)°
3-Methyl-4-[(<i>Z</i>)-2-(4-methylphenyl)hydrazin-1-ylidene]-1-(3-nitrophenyl)-1<i>H</i>-pyrazol-5(4<i>H</i>)-one
C17H15N5O3
Acta Crystallographica Section C Structural Chemistry (2014) 70, 9
a=16.474(4)Å b=13.189(3)Å c=15.113(4)Å
α=90.00° β=98.031(4)° γ=90.00°
3-Methyl-4-[(<i>Z</i>)-2-(4-methylphenyl)hydrazin-1-ylidene]-1-[4-(trifluoromethyl)phenyl]-1<i>H</i>-pyrazol-5(4<i>H</i>)-one
C18H15F3N4O
Acta Crystallographica Section C Structural Chemistry (2014) 70, 9
a=8.4570(4)Å b=9.8227(5)Å c=11.2448(6)Å
α=103.327(2)° β=107.761(2)° γ=100.242(2)°
(<i>E</i>)-1-(4-{[1-(4-Fluorophenyl)-3,5-dimethyl-1<i>H</i>-pyrazol-\ 4-yl]diazenyl}phenyl)ethanone
C19H17FN4O
Acta Crystallographica Section C (2015) 71, 1
a=19.392(4)Å b=7.5431(15)Å c=22.754(5)Å
α=90° β=90° γ=90°
(<i>E</i>)-1-(4-Chlorophenyl)-3,5-dimethyl-4-[2-(2-nitrophenyl)diazenyl]-1<i>H</i>-pyrazole
C17H14ClN5O2
Acta Crystallographica Section C (2015) 71, 1
a=14.076(5)Å b=30.549(12)Å c=7.539(3)Å
α=90° β=90° γ=90°
3,5-Dimethyl-4-[(<i>E</i>)-(2-nitrophenyl)diazenyl]- 1-(2,3,4,5,6-pentafluorophenyl)-1<i>H</i>-pyrazole
C17H10F5N5O2
Acta Crystallographica Section C (2013) 69, 1 101-104
a=7.4932(8)Å b=10.5834(11)Å c=11.4141(12)Å
α=102.690(2)° β=100.459(2)° γ=101.986(2)°
(<i>Z</i>)-3-Methyl-4-[2-(4-methylphenyl)hydrazinylidene]-1-(pentafluorophenyl)-1<i>H</i>-pyrazol-5(4<i>H</i>)-one
C17H11F5N4O
Acta Crystallographica Section C (2013) 69, 10 1200-1204
a=11.6678(12)Å b=16.6283(17)Å c=17.8362(18)Å
α=90.00° β=97.368(2)° γ=90.00°
2-[2-(4-Acetylphenyl)hydrazinylidene]-1,3-diphenylpropane-1,3-dione
C23H18N2O3
Acta Crystallographica Section E (2011) 67, 8 o2048-o2049
a=12.6026(15)Å b=11.0138(13)Å c=14.9701(18)Å
α=90° β=114.447(2)° γ=90°
(Acetylacetonato)dibromido[2,2-diphenylhydrazin-1-ido(1-)][2,2- diphenylhydrazin-1-ido(2-)]molybdenum(VI)
C29H28Br2MoN4O2
Acta Crystallographica Section E (2011) 67, 6 m675-m676
a=9.5828(11)Å b=32.187(4)Å c=9.1455(10)Å
α=90° β=94.601(2)° γ=90°
2-[2-(3-Chlorophenyl)hydrazinylidene]-1,3-diphenylpropane-1,3-dione
C21H15ClN2O2
Acta Crystallographica Section E (2011) 67, 6 o1450-o1451
a=10.2970(9)Å b=10.3526(9)Å c=16.8926(15)Å
α=90° β=102.1310(10)° γ=90°
2-[2-(4-Bromophenyl)hydrazinylidene]-1,3-diphenylpropane-1,3-dione
C21H15BrN2O2
Acta Crystallographica Section E (2011) 67, 6 o1426
a=12.0273(9)Å b=10.2977(8)Å c=14.2626(11)Å
α=90° β=96.4520(10)° γ=90°
2-[2-(4-Nitrophenyl)hydrazinylidene]-1,3-diphenylpropane-1,3-dione
C21H15N3O4
Acta Crystallographica Section E (2011) 67, 7 o1587
a=8.2994(7)Å b=8.6250(7)Å c=25.018(2)Å
α=90° β=90° γ=90°
2-[2-(4-methoxyphenyl)hydrazinylidene]-1,3-diphenylpropane-1,3-dione
C22H18N2O3
Acta Crystallographica Section E (2011) 67, 7 o1830-o1831
a=12.3045(11)Å b=11.0550(10)Å c=14.2435(13)Å
α=90° β=113.6830(10)° γ=90°
(<i>E</i>)-3,5-Dimethyl-1-<i>p</i>-tolyl-4-(<i>p</i>-tolyldiazenyl)- 1<i>H</i>-pyrazole
C19H20N4
Acta Crystallographica Section E (2012) 68, 2 o353-o354
a=9.4320(8)Å b=19.1552(17)Å c=18.4511(16)Å
α=90.00° β=101.9310(10)° γ=90.00°
(<i>Z</i>)-1-(2-Chlorophenyl)-3-methyl-4-[2-(4-nitrophenyl)hydrazin-1- ylidene]-1<i>H</i>-pyrazol-5(4<i>H</i>)-one
C16H12ClN5O3
Acta Crystallographica Section E (2012) 68, 8 o2351-o2352
a=7.2715(6)Å b=14.7757(12)Å c=15.7609(12)Å
α=75.4080(10)° β=86.9430(10)° γ=79.7740(10)°
Mo16O52Dy,5(C16H36N),8(C2H3N)
Mo16O52Dy,5(C16H36N),8(C2H3N)
Dalton transactions (Cambridge, England : 2003) (2016) 45, 42 16653-16660
a=17.7626(4)Å b=32.9141(8)Å c=47.7196(12)Å
α=90.00° β=90.00° γ=90.00°